Scarlet Therapeutics Announces Seed Financing to Advance Development of Therapeutic Red Blood Cell Platform
Pioneering platform to generate novel therapies with potential to treat a wide range of diseases Financing led by Science Creates Ventures and Meltwind to fund development of the platform and initial product candidates BRISTOL, England, May 23, 2023 /PRNewswire/ — Scarlet Therapeutics (“Scarlet”), a leader in red blood cell-based therapeutics, announces today that it has … Read more